Professional
Added to YB: 2024-10-25
Pitch date: 2024-10-25
NBY [neutral]
NovaBay Pharmaceuticals, Inc.
+675.81%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Company Info
NovaBay Pharmaceuticals, Inc. does not have significant operations. Previously, the company was engaged in the development and sale of eyecare, wound care, and skin care products in the United States and internationally.
Market Cap
$128.5M
Pitch Price
$0.36
Price Target
N/A
Dividend
N/A
EV/EBITDA
-27.80
P/E
-1.01
EV/Sales
12.77
Sector
Pharmaceuticals
Category
special_situation
NovaBay Pharmaceuticals Faces Liquidation: Potential Opportunity or Risk?
NBY (liquidation - monitoring): Biopharma in liquidation. Sold key asset for $9.5M. Est. liquidation value $3.2M vs $2.9M mcap. $700k cash, $3M liabilities (Sept '24). $4M July raise not reflected. Burn rate $3-4M. Shareholder vote Nov 22. More info needed before investing. Watching closely.
Read full article (1 min)